Collegium Pharmaceutical Inc (COLL)
35.84
+0.36
(+1.01%)
USD |
NASDAQ |
Apr 25, 16:00
35.85
+0.01
(+0.03%)
Pre-Market: 20:00
Collegium Pharmaceutical Cash and Short Term Investments (Quarterly): 310.55M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 310.55M |
| September 30, 2023 | 304.56M |
| June 30, 2023 | 325.47M |
| March 31, 2023 | 269.48M |
| December 31, 2022 | 173.69M |
| September 30, 2022 | 134.13M |
| June 30, 2022 | 122.72M |
| March 31, 2022 | 106.70M |
| December 31, 2021 | 186.43M |
| September 30, 2021 | 193.24M |
| June 30, 2021 | 202.77M |
| March 31, 2021 | 182.79M |
| December 31, 2020 | 174.12M |
| September 30, 2020 | 165.42M |
| June 30, 2020 | 145.68M |
| March 31, 2020 | 116.18M |
| December 31, 2019 | 170.02M |
| September 30, 2019 | 153.84M |
| June 30, 2019 | 148.71M |
| Date | Value |
|---|---|
| March 31, 2019 | 134.91M |
| December 31, 2018 | 146.63M |
| September 30, 2018 | 139.79M |
| June 30, 2018 | 133.75M |
| March 31, 2018 | 128.25M |
| December 31, 2017 | 118.70M |
| September 30, 2017 | 107.61M |
| June 30, 2017 | 111.21M |
| March 31, 2017 | 129.56M |
| December 31, 2016 | 153.22M |
| September 30, 2016 | 91.03M |
| June 30, 2016 | 110.75M |
| March 31, 2016 | 134.73M |
| December 31, 2015 | 95.70M |
| September 30, 2015 | 105.46M |
| June 30, 2015 | 112.41M |
| March 31, 2015 | 44.99M |
| December 31, 2014 | 1.634M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
106.70M
Minimum
Mar 2022
325.47M
Maximum
Jun 2023
188.76M
Average
173.69M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Immunogen Inc (DELISTED) | 605.54M |
| Supernus Pharmaceuticals Inc | 254.87M |
| AnaptysBio Inc | 390.90M |
| Recursion Pharmaceuticals Inc | 391.56M |
| Nuvalent Inc | 719.90M |